Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Celularity (CELU) Long-Term Deferred Tax (2024 - 2025)

Celularity (CELU) has disclosed Long-Term Deferred Tax for 2 consecutive years, with $192.6 million as the latest value for Q4 2025.

For Q4 2025, Long-Term Deferred Tax rose 6.15% year-over-year to $192.6 million; the TTM value through Dec 2025 reached $192.6 million, up 6.15%, while the annual FY2025 figure was $192.6 million, 6.15% up from the prior year.
Long-Term Deferred Tax hit $192.6 million in Q4 2025 for Celularity, up from $181.4 million in the prior quarter.
Across five years, Long-Term Deferred Tax topped out at $192.6 million in Q4 2025 and bottomed at $181.4 million in Q4 2024.